Evidence map›Paper›PMID 35569346›Full record

ArticleJournal of reproductive immunology2022

Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment".

Michael Ceulemans, Laure Sillis, Veerle Foulon, Alice Panchaud, Ursula Winterfeld, Léo Pomar, Brian Cleary, Fergal O'Shaughnessy, Anneke Passier, Jonathan Luke Richardson and 1 more

Abstract readLetterComment
In one paragraph

Article in Journal of reproductive immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Michael CeulemansClinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium; Teratology Information Service, Pharmacovigilance Centre Lareb, The Netherlands; L-C&Y, KU Leuven Child & Youth Institute, Belgium.
Laure SillisClinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium.
Veerle FoulonClinical Pharmacology & Pharmacotherapy, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Belgium.
Alice PanchaudService of Pharmacy, Lausanne University Hospital and University of Lausanne, Switzerland; Institute of Primary Health Care (BIHAM), University of Bern, Switzerland.
Ursula WinterfeldSwiss Teratogen Information Service, Clinical Pharmacology Service, Lausanne University Hospital, Switzerland.
Léo PomarMaterno-Fetal and Obstetrics Research Unit, Lausanne University Hospital, Switzerland; School of Health Sciences (HESAV), University of Applied Sciences and Arts Western Switzerland, Switzerland.
Brian ClearyRotunda Hospital, Ireland; School of Pharmacy, Royal College of Surgeons Ireland, Ireland.
Fergal O'ShaughnessyRotunda Hospital, Ireland; School of Pharmacy, Royal College of Surgeons Ireland, Ireland.
Anneke PassierTeratology Information Service, Pharmacovigilance Centre Lareb, The Netherlands.
Jonathan Luke RichardsonUK Teratology Information Service, Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.
Hedvig NordengPharmacoepidemiology and Drug Safety Research Group, Department of Pharmacy, and PharmaTox Strategic Initiative, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway; Department of Child Health and Development, Norwegian Institute of Public Health, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19VaccinesFemaleHumansPregnancyVaccinationVaccines

Identifiers

PMID35569346
PMCPMC9088047

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.